Sai Life Sciences IPO Subscription Status

Sai Life Sciences IPO Subscription Status
Sai Life Sciences IPO subscription started on 11 December, 2024 and will close on 13 December, 2024. The retail quota is 35%, QIB is 50% and NII is 15%. Sai Life Sciences IPO got a lot of interest, raising around ₹3042.62 Crores, with subscriptions 10.27 times overall, including 29.78 times by institutional investors, 4.99 times by non-institutional investors, and 1.39 times by retail investors. Shares are priced between ₹522-549 each and will be listed on the BSE and NSE.
  Check Live IPO  Subscription List  👈
Listed
Last Updated - December 13, 2024 11:55 pm

Sai Life Sciences IPO Subscription - Day 3

QIB - Qualified Institutional Buyers:29.78x
NII - Non-Institutional Investors:4.99x
SNII - Small Non-Institutional Investors:2.78x
BNII - Big Non-Institutional Investors:6.1x
RII - Retail Individual Investor:1.39x
Total:10.27x 👈

Sai Life Sciences IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Sai Life Sciences IPO Dates

IPO ActivityDate
Open Date:11 December, 2024
Close Date:13 December, 2024
Allotment Date:16 December, 2024
Refund Date:17 December, 2024
Shares Credit Date:17 December, 2024
Listing Date:18 December, 2024

Sai Life Sciences IPO Subscription Status FAQs

Q.When Sai Life Sciences IPO Subscription will start?

Ans.The IPO subscription starts on 11 December, 2024 for Investors.


Q.What is the Sai Life Sciences IPO Subscription last date?

Ans.Sai Life Sciences IPO subscription last date is 13 December, 2024 for Investors.


Q.What is the Sai Life Sciences IPO Allotment Date?

Ans.Sai Life Sciences IPO allotment date is 16 December, 2024.


Q.What is the Sai Life Sciences IPO Listing Date?

Ans.Sai Life Sciences IPO listing date is 18 December, 2024. The IPO is to list on BSE and NSE.

Leave a Comment

Your email address will not be published. Required fields are marked *